[Factors of pathogenicity in beta-hemolysing streptococci].
D000942:Antigens, Bacterial; D001426:Bacterial Proteins / Q000276:immunology; D002462:Cell Membrane / Q000276:immunology; D002467:Cell Nucleus / Q000276:immunology; D002473:Cell Wall / Q000276:immunology; D006461:Hemolysis; D006801:Humans; D006820:Hyaluronic Acid / Q000494:pharmacology; D008961:Models, Structural; D009088:Mucoproteins / Q000276:immunology / Q000633:toxicity; D010587:Phagocytosis / Q000187:drug effects; D011135:Polysaccharides, Bacterial; D012270:Ribosomes / Q000276:immunology; D012703:Serotyping; D013290:Streptococcal Infections / Q000209:etiology / Q000276:immunology; D013291:Streptococcus / Q000145:classification / Q000472:pathogenicity* / Q000648:ultrastructure; D013682:Teichoic Acids / Q000276:immunology; D014774:Virulence
D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D009088:Mucoproteins; D011135:Polysaccharides, Bacterial; D013682:Teichoic Acids; D006820:Hyaluronic Acid
Pathogenitätsfaktoren beta-hämolysierender Streptokokken